Intermittent Oro-esophageal Tube Feeding on Dysphagia in Stroke Survivor

Launched by COPKA SONPASHAN · Mar 18, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two different ways of providing nutrition can help stroke survivors who have difficulty swallowing, a condition known as dysphagia. In the trial, patients will be divided into two groups: one group will receive nutrition through a tube placed in the mouth and throat (called intermittent oro-esophageal tube feeding), while the other group will receive nutrition through a tube placed in the nose (known as nasogastric tube feeding). Both groups will also receive rehabilitation therapy to help improve their overall recovery. Researchers will compare how these methods affect the patients' nutritional status, swallowing ability, quality of life, and feelings of depression before and after treatment.

To be eligible for this trial, participants must be at least 18 years old, have had a stroke, and have some level of difficulty swallowing when they are admitted to the hospital. They should also be in stable health and able to participate in assessments. However, individuals with other serious health conditions or certain complications will not be included in the study. For those who qualify, participating in the trial will involve receiving specialized feeding methods while also engaging in rehabilitation activities to support their recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age ≥ 18 years;
• • meeting the diagnostic criteria of stroke;
• • any degree of dysphagia at admission;
• • steady vital signs, without severe cognitive impairment or sensory aphasia, able to cooperate with the assessment.
• • transferred out within three weeks of hospitalization in the neurology department.
• Exclusion Criteria:
• • complicated with other neurological diseases;
• • damaged mucosa or incomplete structure in nasopharynx;
• • tracheostomy tube plugged;
• • unfeasible to the support of parenteral nutrition;
• • simultaneously suffering from liver, kidney failure, tumors, or hematological diseases.